Form D · Other
Symbiome, Inc.
San Francisco, CA · CIK 0001815492
Offering snapshot reported Sep 29, 2020 · SEC filing
- Reported sold
- $100K Offering amount: $100K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Sep 11, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 29, 2020 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Jun 19, 2020 | Initial | $7,174,999 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-376615
Source: Form D, filed Sep 29, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Adam D'augelli | Director |
| Adam Klausner | Executive |
| Vicki Levine | Director, Executive |
| Larry Weiss | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
953 Indiana Street
San Francisco, CA, 94107
San Francisco, CA, 94107